Skip to main content

April 2018, Nephrology News & Issues: Medicare payment for Parsabiv and Sensipar moves to Part B, by Sarah Tolson and Rick Collins

Editor’s note: In January, both Parsabiv and Sensipar moved from the Medicare Part D reimbursement to Part B for patients with end-stage renal disease. We asked Sarah Tolson and Rick Collins at Sceptre Management Solutions to explain how the change impacts dialysis providers and physicians.

Read the full article at: